内容为空 gogo jili app download

Your current location: https://cpf23.cc.dev.tp.wrayward.dev/cpresources/twentytwentyfive/>mnl168 games

gogo jili app download

2025-01-09mnl168 games 编辑:gogo jili app download


gogo jili app download
gogo jili app download Eight dead in Mexico shooting

Arcane’s two seasons may have cost Riot Games so much they ran away from HollywoodPLEASANTON, Calif. , Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the risk of disruption to ongoing research, 10x Genomics requested a carve-out for GeoMx users who installed an instrument prior to the trial in November 2023 . The injunction, which the Court said it will enter in January 2025 , is expected to prohibit Bruker from making, using, selling or offering to sell in the United States its GeoMx Digital Spatial Profiler and associated instruments, reagents and services for RNA and protein detection. At the request of 10x Genomics, the injunction will not block ongoing research by researchers who installed a GeoMx instrument prior to November 18, 2023 . Such customers can continue to purchase GeoMx reagents for use with existing GeoMx instruments for purposes of continuing their ongoing research. The Court found that making such an exception for ongoing research strikes a "workable balance between protecting the patentee's rights and protecting the public from the injunction's adverse effects." In addition, the Court affirmed the $31 million damages awarded by the November 2023 jury verdict, as well as supplemental damages and interest that will be added to the total damages when final judgment is entered. "Today's decision helps to safeguard our decade-long investment in innovation and ensures we can continue to develop groundbreaking technologies that help our customers revolutionize science," said Eric Whitaker , Chief Legal Officer at 10x Genomics. "10x exists to fuel scientific progress – not stifle it – and that is why we've done our utmost to ensure this injunction was structured to protect both our intellectual property and existing GeoMx customers' ongoing research." The Court recognized the harm NanoString's infringing conduct caused 10x when it wrote in its ruling, "Having been careful not to license its technology, 10x suffers when it proclaims itself as an innovator in spatial genomics but a competitor is using the same innovative, patented technology." Today's Court decision follows a November 2023 jury verdict that found that NanoString's GeoMx products willfully infringed seven patents exclusively licensed to 10x Genomics by Prognosys. During the trial, the jury heard testimony from the sole inventor of the patents, Illumina co-founder Mark Chee , and NanoString CEO Brad Gray and NanoString CSO Joe Beechem. After hearing all of the evidence, the jury determined that all seven patents had been infringed by NanoString, that each patent was valid, that NanoString willfully infringed those patents and that monetary damages were owed to 10x for the infringement of all seven patents. In affirming the jury's finding that NanoString willfully infringed, the Court relied on the evidence showing that NanoString knew or was willfully blind that its acts would cause infringement of 10x's rights. The asserted patents in Case No. 21-cv-653-MFK include (a) U.S. Patent No. 10,472,669; (b) U.S. Patent No. 10,961,566; (c) U.S. Patent No. 10,983,113; (d) U.S. Patent No. 10,996,219; (e) U.S. Patent No. 11,001,878; (f) U.S. Patent No. 11,008,607 and (g) U.S. Patent No. 11,293,917. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter) . Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. All statements included in this press release, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "see," "estimate," "predict," "potential," "would," "likely," "seek" or "continue" or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding litigation and remedies as well as possible outcomes of litigation. These forward-looking statements do not reflect that our success will depend on our ability to obtain, maintain and protect our intellectual property rights, intellectual property litigation could be expensive, time-consuming, unsuccessful and could interfere with our ability to develop, manufacture and commercialize our products or technologies, litigation outcomes are unpredictable or there may be changes in our litigation strategy. These statements are based on management's current expectations, forecasts, beliefs, assumptions and information currently available to management. Actual outcomes and results could differ materially from these statements due to a number of factors and such statements should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. The material risks and uncertainties that could affect 10x Genomics, Inc.'s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's most recently-filed 10-K for the fiscal year ended December 31, 2023 and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time. Disclosure Information 10x Genomics uses filings with the Securities and Exchange Commission, our website ( www.10xgenomics.com ), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Contacts Investors: investors@10xgenomics.com Media: media@10xgenomics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/us-district-court-awards-10x-genomics-permanent-injunction-in-patent-infringement-lawsuit-against-bruker-corporations-geomx-products-302338627.html SOURCE 10x Genomics, Inc.By Connor Smith The stock market rallied in the final hour of trading on Monday as those still on Wall Street looked to get their last trades in before the market closes early on Christmas Eve. The Dow Jones Industrial Average was up 67 points, or 0.2%. The S&P 500 was up 0.7%. The Nasdaq Composite was up 1%. Technology stocks were rising all day, but the Dow and a larger chunk of the S&P joined in the rally shortly before the market closed. A majority of S&P 500 stocks closed higher for the second trading day in a row. The yield on the 2-year Treasury note was up to 4.35%. The 10-year yield was up to 4.59%.

The most startup-friendly countries in 2024

Friends, colleagues remember former state Rep. Mary MurphyVan Zandt County, Kilgore and others awarded grants for emergency radio infrastructure

investwfg.com: A Leading Platform Serving Over 5 Million High-Net-Worth Users Worldwide 12-26-2024 08:24 PM CET | Business, Economy, Finances, Banking & Insurance Press release from: Getnews / PR Agency: Stones_PR investwfg.com, a premier internet-based financial services platform, has surpassed a major milestone, announcing that it has now served more than 5 million high-net-worth individuals worldwide. This marks a significant achievement for the platform, which has established itself as a trusted resource for sophisticated investors looking for comprehensive financial solutions. For years, investwfg.com has provided an array of services tailored to meet the unique needs of affluent clients across the globe. From advanced investment strategies to wealth management and estate planning, the platform has become an essential tool for those seeking personalized financial guidance and innovative solutions in an increasingly complex global market. Image: https://www.timesnewswire.com/wp-content/uploads/2024/12/11-3.jpg A Global Reach With a diverse customer base spread across various continents, investwfg.com has proven to be a vital partner in the wealth management journey of individuals with significant financial assets. Its global approach has enabled the platform to cater to the varied financial landscapes, offering expert insights into international markets, risk management, and investment diversification. "We are thrilled to have reached such a remarkable milestone," said, CEO of investwfg.com. "This achievement reflects the trust and confidence that high-net-worth individuals have placed in our platform. We remain committed to delivering unparalleled financial expertise and personalized services to meet the evolving needs of our clientele." Advanced Financial Tools for High-Net-Worth Individuals investwfg.com offers cutting-edge financial tools and services that are designed to address the complexities of managing substantial wealth. Clients can access a wide range of offerings, including: Custom Investment Portfolios: Tailored to individual risk profiles and financial goals. Global Market Insights: Real-time analysis and expert forecasts for various international markets. Tax Optimization Strategies: Guidance on minimizing tax liabilities across borders. Estate and Succession Planning: Ensuring the smooth transfer of wealth for future generations. Alternative Investments: Access to exclusive investment opportunities outside traditional equities and bonds. These services are backed by a team of seasoned professionals with expertise in investment management, tax planning, and legal matters, ensuring that each client's wealth is protected and optimized for growth. Image: https://www.timesnewswire.com/wp-content/uploads/2024/12/22-1.jpg A Platform Built on Trust and Security One of the key factors contributing to investwfg.com's success is its unwavering focus on security and client privacy. The platform employs the latest encryption and cybersecurity technologies to safeguard personal and financial data, providing clients with peace of mind in an increasingly digital world. Looking Ahead As investwfg.com continues to grow, the platform remains focused on expanding its range of services and enhancing user experience. With the financial landscape constantly evolving, the platform is committed to staying at the forefront of innovation, offering clients cutting-edge solutions to help them navigate the challenges of wealth management in the 21st century. About investwfg.com Founded ten years ago, investwfg.com has become a leader in the online wealth management industry. With a reputation for excellence and a dedication to providing personalized, high-quality financial services, the platform serves an elite group of clients from all corners of the globe. Whether through strategic investment opportunities, estate planning, or financial risk management, investwfg.com continues to redefine what it means to be a trusted partner in wealth management. Conclusion investwfg.com's milestone of serving over 5 million high-net-worth clients reflects its ongoing success in the competitive world of internet-based financial platforms. The company's commitment to providing sophisticated financial tools and expert guidance remains a cornerstone of its appeal, making it a go-to destination for individuals looking to secure and grow their wealth. Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements. Media Contact Company Name: INVESTWFG Contact Person: JACK LEVIN Email: Send Email [ http://www.universalpressrelease.com/?pr=investwfgcom-a-leading-platform-serving-over-5-million-highnetworth-users-worldwide ] Country: United States Website: http://www.investwfg.com This release was published on openPR.Bears-Seahawks inactives report: DL Gervon Dexter returns from knee injuryADC Therapeutics Makes Grants to New Employees Under Inducement PlanNone


Previous:

Next: gogo jili helens



  • This website reprints and indicates that the works are from other sources for the purpose of delivering more information. It does not mean that this website agrees with their views or confirms the authenticity of their content. We do not bear direct responsibility and joint liability for the infringement of such works. When other media, websites or individuals reprint from this website, they must retain the source of the works indicated by this website and bear the legal responsibilities such as copyright.
  • If there are any issues regarding the content, copyright, etc. of the work, please contact this website within one week from the date of publication of the work, otherwise it will be deemed as giving up the relevant rights.